Global Inhalers Market Insights and Forecast to 2028

Publisher Name :
Date: 02-Mar-2022
No. of pages: 114
Inquire Before Buying

Inhalers market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Inhalers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Metered Dose Inhalers

- Dry Powder Inhalers

- Nasal Inhalers

- Other

Segment by Application

- Hospital

- Clinic

- Respiratory Care Centers

- Others

By Company

- GlaxoSmithKline

- Merck

- AstraZeneca

- Boehringer-Ingelheim

- 3M

- Teva

- Sunovion Pharmaceuticals

- Aristopharma

- Novartis

- Vectura Group

- MannKind

- Respirices

- Orion Pharm

- Hovione

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Inhalers Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Inhalers Product Introduction
1.2 Market by Type
1.2.1 Global Inhalers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Metered Dose Inhalers
1.2.3 Dry Powder Inhalers
1.2.4 Nasal Inhalers
1.2.5 Other
1.3 Market by Application
1.3.1 Global Inhalers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Respiratory Care Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Inhalers Sales Estimates and Forecasts 2017-2028
2.2 Global Inhalers Revenue Estimates and Forecasts 2017-2028
2.3 Global Inhalers Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Inhalers Sales by Region
2.4.1 Global Inhalers Sales by Region (2017-2022)
2.4.2 Global Sales Inhalers by Region (2023-2028)
2.5 Global Inhalers Revenue by Region
2.5.1 Global Inhalers Revenue by Region (2017-2022)
2.5.2 Global Inhalers Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Inhalers Sales by Manufacturers
3.1.1 Global Top Inhalers Manufacturers by Sales (2017-2022)
3.1.2 Global Inhalers Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inhalers in 2021
3.2 Global Inhalers Revenue by Manufacturers
3.2.1 Global Inhalers Revenue by Manufacturers (2017-2022)
3.2.2 Global Inhalers Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Inhalers Revenue in 2021
3.3 Global Inhalers Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inhalers Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inhalers Sales by Type
4.1.1 Global Inhalers Historical Sales by Type (2017-2022)
4.1.2 Global Inhalers Forecasted Sales by Type (2023-2028)
4.1.3 Global Inhalers Sales Market Share by Type (2017-2028)
4.2 Global Inhalers Revenue by Type
4.2.1 Global Inhalers Historical Revenue by Type (2017-2022)
4.2.2 Global Inhalers Forecasted Revenue by Type (2023-2028)
4.2.3 Global Inhalers Revenue Market Share by Type (2017-2028)
4.3 Global Inhalers Price by Type
4.3.1 Global Inhalers Price by Type (2017-2022)
4.3.2 Global Inhalers Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Inhalers Sales by Application
5.1.1 Global Inhalers Historical Sales by Application (2017-2022)
5.1.2 Global Inhalers Forecasted Sales by Application (2023-2028)
5.1.3 Global Inhalers Sales Market Share by Application (2017-2028)
5.2 Global Inhalers Revenue by Application
5.2.1 Global Inhalers Historical Revenue by Application (2017-2022)
5.2.2 Global Inhalers Forecasted Revenue by Application (2023-2028)
5.2.3 Global Inhalers Revenue Market Share by Application (2017-2028)
5.3 Global Inhalers Price by Application
5.3.1 Global Inhalers Price by Application (2017-2022)
5.3.2 Global Inhalers Price Forecast by Application (2023-2028)
6 North America
6.1 North America Inhalers Market Size by Type
6.1.1 North America Inhalers Sales by Type (2017-2028)
6.1.2 North America Inhalers Revenue by Type (2017-2028)
6.2 North America Inhalers Market Size by Application
6.2.1 North America Inhalers Sales by Application (2017-2028)
6.2.2 North America Inhalers Revenue by Application (2017-2028)
6.3 North America Inhalers Market Size by Country
6.3.1 North America Inhalers Sales by Country (2017-2028)
6.3.2 North America Inhalers Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Inhalers Market Size by Type
7.1.1 Europe Inhalers Sales by Type (2017-2028)
7.1.2 Europe Inhalers Revenue by Type (2017-2028)
7.2 Europe Inhalers Market Size by Application
7.2.1 Europe Inhalers Sales by Application (2017-2028)
7.2.2 Europe Inhalers Revenue by Application (2017-2028)
7.3 Europe Inhalers Market Size by Country
7.3.1 Europe Inhalers Sales by Country (2017-2028)
7.3.2 Europe Inhalers Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Inhalers Market Size by Type
8.1.1 Asia Pacific Inhalers Sales by Type (2017-2028)
8.1.2 Asia Pacific Inhalers Revenue by Type (2017-2028)
8.2 Asia Pacific Inhalers Market Size by Application
8.2.1 Asia Pacific Inhalers Sales by Application (2017-2028)
8.2.2 Asia Pacific Inhalers Revenue by Application (2017-2028)
8.3 Asia Pacific Inhalers Market Size by Region
8.3.1 Asia Pacific Inhalers Sales by Region (2017-2028)
8.3.2 Asia Pacific Inhalers Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Inhalers Market Size by Type
9.1.1 Latin America Inhalers Sales by Type (2017-2028)
9.1.2 Latin America Inhalers Revenue by Type (2017-2028)
9.2 Latin America Inhalers Market Size by Application
9.2.1 Latin America Inhalers Sales by Application (2017-2028)
9.2.2 Latin America Inhalers Revenue by Application (2017-2028)
9.3 Latin America Inhalers Market Size by Country
9.3.1 Latin America Inhalers Sales by Country (2017-2028)
9.3.2 Latin America Inhalers Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Inhalers Market Size by Type
10.1.1 Middle East and Africa Inhalers Sales by Type (2017-2028)
10.1.2 Middle East and Africa Inhalers Revenue by Type (2017-2028)
10.2 Middle East and Africa Inhalers Market Size by Application
10.2.1 Middle East and Africa Inhalers Sales by Application (2017-2028)
10.2.2 Middle East and Africa Inhalers Revenue by Application (2017-2028)
10.3 Middle East and Africa Inhalers Market Size by Country
10.3.1 Middle East and Africa Inhalers Sales by Country (2017-2028)
10.3.2 Middle East and Africa Inhalers Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Overview
11.3.3 AstraZeneca Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AstraZeneca Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AstraZeneca Recent Developments
11.4 Boehringer-Ingelheim
11.4.1 Boehringer-Ingelheim Corporation Information
11.4.2 Boehringer-Ingelheim Overview
11.4.3 Boehringer-Ingelheim Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boehringer-Ingelheim Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer-Ingelheim Recent Developments
11.5 3M
11.5.1 3M Corporation Information
11.5.2 3M Overview
11.5.3 3M Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 3M Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 3M Recent Developments
11.6 Teva
11.6.1 Teva Corporation Information
11.6.2 Teva Overview
11.6.3 Teva Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Recent Developments
11.7 Sunovion Pharmaceuticals
11.7.1 Sunovion Pharmaceuticals Corporation Information
11.7.2 Sunovion Pharmaceuticals Overview
11.7.3 Sunovion Pharmaceuticals Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sunovion Pharmaceuticals Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sunovion Pharmaceuticals Recent Developments
11.8 Aristopharma
11.8.1 Aristopharma Corporation Information
11.8.2 Aristopharma Overview
11.8.3 Aristopharma Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Aristopharma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Aristopharma Recent Developments
11.9 Novartis
11.9.1 Novartis Corporation Information
11.9.2 Novartis Overview
11.9.3 Novartis Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Novartis Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Novartis Recent Developments
11.10 Vectura Group
11.10.1 Vectura Group Corporation Information
11.10.2 Vectura Group Overview
11.10.3 Vectura Group Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vectura Group Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vectura Group Recent Developments
11.11 MannKind
11.11.1 MannKind Corporation Information
11.11.2 MannKind Overview
11.11.3 MannKind Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 MannKind Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 MannKind Recent Developments
11.12 Respirices
11.12.1 Respirices Corporation Information
11.12.2 Respirices Overview
11.12.3 Respirices Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Respirices Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Respirices Recent Developments
11.13 Orion Pharm
11.13.1 Orion Pharm Corporation Information
11.13.2 Orion Pharm Overview
11.13.3 Orion Pharm Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Orion Pharm Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Orion Pharm Recent Developments
11.14 Hovione
11.14.1 Hovione Corporation Information
11.14.2 Hovione Overview
11.14.3 Hovione Inhalers Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Hovione Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Hovione Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inhalers Industry Chain Analysis
12.2 Inhalers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhalers Production Mode & Process
12.4 Inhalers Sales and Marketing
12.4.1 Inhalers Sales Channels
12.4.2 Inhalers Distributors
12.5 Inhalers Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inhalers Industry Trends
13.2 Inhalers Market Drivers
13.3 Inhalers Market Challenges
13.4 Inhalers Market Restraints
14 Key Findings in The Global Inhalers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Inhalers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Metered Dose Inhalers
Table 3. Major Manufacturers of Dry Powder Inhalers
Table 4. Major Manufacturers of Nasal Inhalers
Table 5. Major Manufacturers of Other
Table 6. Global Inhalers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Inhalers Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Inhalers Sales by Region (2017-2022) & (K Units)
Table 9. Global Inhalers Sales Market Share by Region (2017-2022)
Table 10. Global Inhalers Sales by Region (2023-2028) & (K Units)
Table 11. Global Inhalers Sales Market Share by Region (2023-2028)
Table 12. Global Inhalers Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Inhalers Revenue Market Share by Region (2017-2022)
Table 14. Global Inhalers Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Inhalers Revenue Market Share by Region (2023-2028)
Table 16. Global Inhalers Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Inhalers Sales Share by Manufacturers (2017-2022)
Table 18. Global Inhalers Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Inhalers Revenue Share by Manufacturers (2017-2022)
Table 20. Inhalers Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Inhalers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalers as of 2021)
Table 23. Inhalers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Inhalers Product Offered
Table 25. Date of Manufacturers Enter into Inhalers Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Inhalers Sales by Type (2017-2022) & (K Units)
Table 28. Global Inhalers Sales by Type (2023-2028) & (K Units)
Table 29. Global Inhalers Sales Share by Type (2017-2022)
Table 30. Global Inhalers Sales Share by Type (2023-2028)
Table 31. Global Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Inhalers Revenue Share by Type (2017-2022)
Table 34. Global Inhalers Revenue Share by Type (2023-2028)
Table 35. Inhalers Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Inhalers Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Inhalers Sales by Application (2017-2022) & (K Units)
Table 38. Global Inhalers Sales by Application (2023-2028) & (K Units)
Table 39. Global Inhalers Sales Share by Application (2017-2022)
Table 40. Global Inhalers Sales Share by Application (2023-2028)
Table 41. Global Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Inhalers Revenue Share by Application (2017-2022)
Table 44. Global Inhalers Revenue Share by Application (2023-2028)
Table 45. Inhalers Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Inhalers Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Inhalers Sales by Type (2017-2022) & (K Units)
Table 48. North America Inhalers Sales by Type (2023-2028) & (K Units)
Table 49. North America Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Inhalers Sales by Application (2017-2022) & (K Units)
Table 52. North America Inhalers Sales by Application (2023-2028) & (K Units)
Table 53. North America Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Inhalers Sales by Country (2017-2022) & (K Units)
Table 56. North America Inhalers Sales by Country (2023-2028) & (K Units)
Table 57. North America Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Inhalers Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Inhalers Sales by Type (2017-2022) & (K Units)
Table 60. Europe Inhalers Sales by Type (2023-2028) & (K Units)
Table 61. Europe Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Inhalers Sales by Application (2017-2022) & (K Units)
Table 64. Europe Inhalers Sales by Application (2023-2028) & (K Units)
Table 65. Europe Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Inhalers Sales by Country (2017-2022) & (K Units)
Table 68. Europe Inhalers Sales by Country (2023-2028) & (K Units)
Table 69. Europe Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Inhalers Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Inhalers Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Inhalers Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Inhalers Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Inhalers Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Inhalers Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Inhalers Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Inhalers Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Inhalers Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Inhalers Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Inhalers Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Inhalers Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Inhalers Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Inhalers Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Inhalers Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Inhalers Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Inhalers Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Inhalers Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Inhalers Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Inhalers Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Inhalers Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Inhalers Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Inhalers Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Inhalers Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Inhalers Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Inhalers Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Inhalers Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Inhalers Revenue by Country (2023-2028) & (US$ Million)
Table 107. GlaxoSmithKline Corporation Information
Table 108. GlaxoSmithKline Description and Major Businesses
Table 109. GlaxoSmithKline Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. GlaxoSmithKline Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. GlaxoSmithKline Recent Developments
Table 112. Merck Corporation Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Merck Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. AstraZeneca Corporation Information
Table 118. AstraZeneca Description and Major Businesses
Table 119. AstraZeneca Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. AstraZeneca Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. AstraZeneca Recent Developments
Table 122. Boehringer-Ingelheim Corporation Information
Table 123. Boehringer-Ingelheim Description and Major Businesses
Table 124. Boehringer-Ingelheim Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Boehringer-Ingelheim Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Boehringer-Ingelheim Recent Developments
Table 127. 3M Corporation Information
Table 128. 3M Description and Major Businesses
Table 129. 3M Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. 3M Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. 3M Recent Developments
Table 132. Teva Corporation Information
Table 133. Teva Description and Major Businesses
Table 134. Teva Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Teva Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Teva Recent Developments
Table 137. Sunovion Pharmaceuticals Corporation Information
Table 138. Sunovion Pharmaceuticals Description and Major Businesses
Table 139. Sunovion Pharmaceuticals Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Sunovion Pharmaceuticals Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Sunovion Pharmaceuticals Recent Developments
Table 142. Aristopharma Corporation Information
Table 143. Aristopharma Description and Major Businesses
Table 144. Aristopharma Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Aristopharma Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Aristopharma Recent Developments
Table 147. Novartis Corporation Information
Table 148. Novartis Description and Major Businesses
Table 149. Novartis Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Novartis Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Novartis Recent Developments
Table 152. Vectura Group Corporation Information
Table 153. Vectura Group Description and Major Businesses
Table 154. Vectura Group Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Vectura Group Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Vectura Group Recent Developments
Table 157. MannKind Corporation Information
Table 158. MannKind Description and Major Businesses
Table 159. MannKind Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. MannKind Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. MannKind Recent Developments
Table 162. Respirices Corporation Information
Table 163. Respirices Description and Major Businesses
Table 164. Respirices Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Respirices Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Respirices Recent Developments
Table 167. Orion Pharm Corporation Information
Table 168. Orion Pharm Description and Major Businesses
Table 169. Orion Pharm Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 170. Orion Pharm Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Orion Pharm Recent Developments
Table 172. Hovione Corporation Information
Table 173. Hovione Description and Major Businesses
Table 174. Hovione Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 175. Hovione Inhalers Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Hovione Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Inhalers Distributors List
Table 180. Inhalers Customers List
Table 181. Inhalers Market Trends
Table 182. Inhalers Market Drivers
Table 183. Inhalers Market Challenges
Table 184. Inhalers Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Inhalers Product Picture
Figure 3. Global Inhalers Market Share by Type in 2021 & 2028
Figure 3. Metered Dose Inhalers Product Picture
Figure 4. Dry Powder Inhalers Product Picture
Figure 5. Nasal Inhalers Product Picture
Figure 6. Other Product Picture
Figure 7. Global Inhalers Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Respiratory Care Centers
Figure 11. Others
Figure 12. Inhalers Report Years Considered
Figure 13. Global Inhalers Sales 2017-2028 (K Units)
Figure 14. Global Inhalers Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Inhalers Revenue 2017-2028 (US$ Million)
Figure 16. Global Inhalers Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Inhalers Sales Market Share by Region (2017-2022)
Figure 18. Global Inhalers Sales Market Share by Region (2023-2028)
Figure 19. North America Inhalers Sales YoY (2017-2028) & (K Units)
Figure 20. North America Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Inhalers Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Inhalers Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Inhalers Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Inhalers Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Inhalers Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Inhalers Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Inhalers in the World: Market Share by Inhalers Revenue in 2021
Figure 31. Global Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Inhalers Sales Market Share by Type (2017-2028)
Figure 33. Global Inhalers Revenue Market Share by Type (2017-2028)
Figure 34. Global Inhalers Sales Market Share by Application (2017-2028)
Figure 35. Global Inhalers Revenue Market Share by Application (2017-2028)
Figure 36. North America Inhalers Sales Market Share by Type (2017-2028)
Figure 37. North America Inhalers Revenue Market Share by Type (2017-2028)
Figure 38. North America Inhalers Sales Market Share by Application (2017-2028)
Figure 39. North America Inhalers Revenue Market Share by Application (2017-2028)
Figure 40. North America Inhalers Sales Share by Country (2017-2028)
Figure 41. North America Inhalers Revenue Share by Country (2017-2028)
Figure 42. U.S. Inhalers Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Inhalers Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Inhalers Sales Market Share by Type (2017-2028)
Figure 45. Europe Inhalers Revenue Market Share by Type (2017-2028)
Figure 46. Europe Inhalers Sales Market Share by Application (2017-2028)
Figure 47. Europe Inhalers Revenue Market Share by Application (2017-2028)
Figure 48. Europe Inhalers Sales Share by Country (2017-2028)
Figure 49. Europe Inhalers Revenue Share by Country (2017-2028)
Figure 50. Germany Inhalers Revenue (2017-2028) & (US$ Million)
Figure 51. France Inhalers Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Inhalers Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Inhalers Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Inhalers Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Inhalers Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Inhalers Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Inhalers Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Inhalers Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Inhalers Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Inhalers Revenue Share by Region (2017-2028)
Figure 61. China Inhalers Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Inhalers Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Inhalers Revenue (2017-2028) & (US$ Million)
Figure 64. India Inhalers Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Inhalers Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Inhalers Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Inhalers Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Inhalers Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Inhalers Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Inhalers Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Inhalers Sales Market Share by Type (2017-2028)
Figure 72. Latin America Inhalers Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Inhalers Sales Market Share by Application (2017-2028)
Figure 74. Latin America Inhalers Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Inhalers Sales Share by Country (2017-2028)
Figure 76. Latin America Inhalers Revenue Share by Country (2017-2028)
Figure 77. Mexico Inhalers Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Inhalers Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Inhalers Revenue (2017-2028) & (US$ Million)
Figure 8
  • Global Pulmonary Drug Delivery Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 143
    According to our LPI (LP Information) latest study, the global Pulmonary Drug Delivery Systems market size was valued at US$ 2979.8 million in 2023. With growing demand in downstream market, the Pulmonary Drug Delivery Systems is forecast to a readjusted size of US$ 4016.5 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Pulmonary Drug Delivery Systems market. Pulmonary Drug Delivery Systems are expected to show s......
  • Global Metered Dose Inhalers Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The Metered Dose Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metered Dose Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides pr......
  • Global Drug Delivery Devices Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Drug Delivery Devices market size was valued at US$ 40490 million in 2023. With growing demand in downstream market, the Drug Delivery Devices is forecast to a readjusted size of US$ 57290 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drug Delivery Devices market. Drug Delivery Devices are expected to show stable growth in the future market. However......
  • Global Nebulizers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Nebulizers market size was valued at US$ 844.1 million in 2023. With growing demand in downstream market, the Nebulizers is forecast to a readjusted size of US$ 1194.4 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Nebulizers market. Nebulizers are expected to show stable growth in the future market. However, product differentiation, reducing costs, ......
  • Global Inhalation Therapy Nebulizer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Inhalation Therapy Nebulizer market size was valued at US$ 1111.6 million in 2023. With growing demand in downstream market, the Inhalation Therapy Nebulizer is forecast to a readjusted size of US$ 1755.2 million by 2030 with a CAGR of 6.7% during review period. The research report highlights the growth potential of the global Inhalation Therapy Nebulizer market. Inhalation Therapy Nebulizer are expected to show stable growth......
  • Global Medical Nebulizer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Medical Nebulizer market size was valued at US$ 1082.4 million in 2023. With growing demand in downstream market, the Medical Nebulizer is forecast to a readjusted size of US$ 1836.1 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Medical Nebulizer market. Medical Nebulizer are expected to show stable growth in the future market. However, product diff......
  • Global Intrathecal Pumps Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Intrathecal Pumps market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Intrathecal Pumps is forecast to a readjusted size of US$ 345.7 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Intrathecal Pumps market. Intrathecal Pumps are expected to show stable growth in the future market. However, product differ......
  • Global Intranasal Drug Delivery Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Intranasal Drug Delivery Devices market size was valued at US$ 1118.1 million in 2023. With growing demand in downstream market, the Intranasal Drug Delivery Devices is forecast to a readjusted size of US$ 2382.3 million by 2030 with a CAGR of 11.4% during review period. The research report highlights the growth potential of the global Intranasal Drug Delivery Devices market. Intranasal Drug Delivery Devices are expected to s......
  • Global Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 156
    According to our (Global Info Research) latest study, the global Drug Delivery Devices market size was valued at USD 42590 million in 2023 and is forecast to a readjusted size of USD 58700 million by 2030 with a CAGR of 4.7% during review period. Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs